Are you a protocol breaker?
|
|
- Donald Green
- 5 years ago
- Views:
Transcription
1 Are you a protocol breaker? Lessons from Diabetic Ketoacidosis Dr Evelyn Tan, Endocrine AT Dr Christopher Rowe, Endocrinologist Department of Endocrinology and Diabetes
2 Outline 5 case vignettes: 1 typical, 4 atypical 2 audits Tertiary Inpatient Management of DKA (2010) Presentations of DKA in dialysis patients, Reflection on the role of protocols and guidelines in medicine
3 Case 1 20yo male found at hotel bathroom unconscious PMHx: 1. T1DM dx age 5 HbA1c 10.9% Mar 17 ICU admissions for DKA 2017, 2016, 2009 x 2 Non-compliance Lantus 15 nocte Novorapid 6-18 TDS No known micro/macro complications 2. Hepatitis C (current IVDU) 3. ADHD 4. Asthma SHx: No fixed abode Released from jail Feb 16 IVDU amphetamines Current smoker Alcohol binge-drink In ED: 140/90, HR 100, afebrile Refused history or examination Verbally aggressive No obvious cellulitis/ injection marks Refused IDC
4 Investigations Admission VBG ph 7.17 Bicarbonate 11.7 Lactate N/A Base excess Glucose 29.0 UEC Sodium 134 Potassium 4.1 Bicarbonate 12 Urea 7.7 Creatinine 125 egfr 71 Other LFT Bilirubin 16 GGT 421 ALP 304 ALT 509 AST 524 FBC WCC 10.3 Hb 160 Platelets 254 HbA1c 10.9% Urine drug screen Positive for amphetamines Capillary ketones 7.1 (<0.4) Beta-hydroxybutyrate 7.5 ( <0.4)
5 Diagnosis: DKA Admission VBG ph 7.17 Bicarbonate 11.7 Lactate N/A Base excess Glucose 29.0 UEC Sodium 134 Potassium 4.1 Bicarbonate 12 Urea 7.7 Creatinine 125 egfr 71 Other LFT Bilirubin 16 GGT 421 ALP 304 ALT 509 AST 524 FBC WCC 10.3 Hb 160 Platelets 254 HbA1c 10.9% Urine drug screen Positive for amphetamines Capillary ketones 7.1 (<0.4) Beta-hydroxybutyrate 7.5 ( <0.4)
6 Diagnosis: DKA Admission VBG ph 7.17 Bicarbonate 11.7 Lactate N/A Base excess Glucose 29.0 UEC Sodium 134 Potassium 4.1 Bicarbonate 12 Urea 7.7 Creatinine 125 egfr 71 Other LFT Bilirubin 16 GGT 421 ALP 304 ALT 509 AST 524 FBC WCC 10.3 Hb 160 Platelets 254 HbA1c 10.9% Urine drug screen Positive for amphetamines Capillary ketones 7.1 (<0.4) Beta-hydroxybutyrate 7.5 ( <0.4)
7 Diabetic Ketoacidosis (DKA) Diagnosis D: Known history of diabetes / elevated glucose AND K: Cap ketones > 3mmol/l AND or urine ketones 2+ A: ph<7.3 or Bicarb <15
8
9 Initial investigations 2 x large bore cannulae VBG, capillary/ urine ketones FBC/UEC/LFT/CMP/formal BGL Find a precipitant Infection blood cultures (x 2), CXR, urine m/c/s Infarction ECG History and physical examination
10 Treatment AIMS : RESOLUTION of ketones and acidosis (ph>7.3, Bicarb >18, cap ketones < 0.5) 1. Fluid status rapid initial fluid replacement in the first few hours (0.9% normal saline) Add 5% dextrose if BGL <15mmol/l Risk of cerebral oedema with children/young adults. 2. Insulin / Glycaemic control Fixed rate insulin (5 units/h) Reduce to 2 units/h if BGL <10 mmol/l Give usual long acting subcut insulin Target BGL mmol/l Suppress ketogenesis 3. Electrolytes Significant potassium shifts Aim Potassium 4-5 mmol/l
11 IVF 1-2L K: 20mmol IVF 1-2L K: 20-40mmol IVF 1.5L K: 10-40mmol First 12 hours: 5L IVF and mmol
12 Progress VBG 0740h 0900h 1010h 1225h 1425h ph Bicarbonate Glucose Potassium Cap ketones Normal saline Actrapid infusion Potassium replacement 5% dextrose
13 Estimate Case 1 IVF 1-2L K: 20mmol IVF 1-2L K: 20-40mmol IVF 1.5L K: 10-40mmol First 12 hours: 5L IVF and mmol K IVF 2.25L K: 10mmol IVF 2.85L K: 50mmol Resolution First 12 hours: 5.1L IVF and 60mmol K
14 Ketones
15 DKA management in HNE Retrospective audit over 12 months 1 Jan Dec 2010 John Hunter, Maitland Hospital, Belmont District Hospital DKA audit standards (UK) Blood gas within 60min from admission IV fluid started within 60min from admission IV insulin started within 120min from admission Cumulative period IV insulin stopped <60min per 24h while on IV insulin Received at least 2 UEC (excluding blood gas) in the first 24h from admission Interval between IV fluid and IV insulin <60min
16 DKA Audit Results: 90 DKA presentations Of which 50 at JHH (i.e. ~1/week) Precipitant 4% 27% 7% 35% 27% Infection Missed insulin New diagnosis Pump malfunction Others
17 DKA Audit - Results 64% received IV fluid within 60min 67% received blood gas within 60min 52% received IV insulin within 120min 33% had IV insulin delayed beyond 180min First 24 hours admission 9% had IV insulin interrupted beyond 60min 24% had potassium <3.5 mmol/l at some point Only 24% overall admissions met the set standards
18 Does a protocol improve efficacy and safety outcomes? Efficacy Safety
19 Cases that don t fit the guideline
20 Cases that don t fit the guideline Cases occurring in abnormal physiology Patients on dialysis Pregnancy Pharmacotherapy
21 Case 2a: Mr A 60 year old male. Diabetes Mellitus diagnosed in 1984 (age 28) On insulin since 1986 Prior episode of DKA in 2015 Social Lives alone, independent Occasional ETOH Non-smoker Microvascular complications Retinopathy (prior photocoagulation) Peripheral neuropathy Biopsy confirmed diabetic nephropathy Commenced PD 2 weeks prior Still passes some urine Hypoglyceamic unawareness (MVA 2016) Macro-vascular risk Treated HTN, Hypercholesterolaemia Medications Lantus 20 units nocte Humalog 10 units meals Verapamil 240mg Aspirin 100mg Rosuvastatin 10mg Calcitriol 0.5microg Calcium 1200mg TDS
22 Case 2a: Presentation 1-2 day history of confusion/vomiting Unclear when last had insulin/dialysis? Self harm Drowsy, confused Afebrile. BP 120/70. P110. Clinically not fluid overloaded No septic focus ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Glucose 73 <11 K Urea Creatinine 958 Osmolality
23 Case 2a: Presentation 1-2 day history of confusion/vomiting Unclear when last had insulin/dialysis? Self harm Drowsy, confused Afebrile. BP 120/70. P110. Clinically not fluid overloaded No septic focus ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Define the key abnormalities 2. How does this situation differ from standard DKA? 3. What is your management priority Glucose 73 <11 K Urea Creatinine 958 Osmolality
24 Case 2a: Presentation 1-2 day history of confusion/vomiting Unclear when last had insulin/dialysis? Self harm Drowsy, confused Afebrile. BP 120/70. P110. Clinically not fluid overloaded No septic focus ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Define the key abnormalities 2. How does this situation differ from standard DKA? 3. What are your management priorities? Glucose 73 <11 K Urea Creatinine 958 Osmolality
25 Case 2a: Presentation Severe high anion gap metabolic acidosis - With respiratory compensation - Explained by ketones + lactate > uraemia Marked hyperglycaemia with compensatory hyponatremia (corrected Na = 146mEq/L) Hyperkalemia with ECG changes Hyperosmolality due to urea and glucose 1. Define the key abnormalities 2. How does this situation differ from standard DKA? 3. What are your management priorities? ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Glucose 73 <11 K Urea Creatinine 958 Osmolality
26 Case 2a: Presentation Severe high anion gap metabolic acidosis - With respiratory compensation - Explained by ketones + lactate > uraemia Marked hyperglycaemia with compensatory hyponatremia (corrected Na = 146mEq/L) Hyperkalemia with ECG changes Hyperosmolality due to urea and glucose 1. Define the key abnormalities 2. How does this situation differ from standard DKA? 3. What are your management priorities? ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Glucose 73 <11 K Urea Creatinine 958 Osmolality
27 Case 2a: Presentation Severe high anion gap metabolic acidosis - With respiratory compensation - Explained by ketones + lactate > uraemia Marked hyperglycaemia with compensatory hyponatremia (corrected Na = 146mEq/L) Hyperkalemia with ECG changes Hyperosmolality due to urea and glucose 1. Define the key abnormalities 2. How does this situation differ from standard DKA? 3. What are your management priorities? ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Glucose 73 <11 K Urea Creatinine 958 Osmolality
28 K 8.0 K 6.7
29 K 8.0 Prolonged QRS Prolonged PR Then loss of P waves Peaked T K 6.7
30 Case 2a: Presentation Severe high anion gap metabolic acidosis - With respiratory compensation - Explained by ketones + lactate > uraemia Marked hyperglycaemia with compensatory hyponatremia (corrected Na = 146mEq/L) Hyperkalemia with ECG changes Hyperosmolality due to urea and glucose 1. Define the key abnormalities 2. How does this situation differ from standard DKA? 3. What are your management priorities? ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Glucose 73 <11 K Urea Creatinine 958 Osmolality
31 Case 2a: Presentation ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Define the key abnormalities 2. How does this situation differ from standard DKA? 3. What are your management priorities? Glucose 73 <11 K Urea Creatinine 958 Osmolality
32 Case 2a: Presentation Unable to generate osmotic diuresis Less likely to have Total body potassium deficit Significant dehydration Dominant cause of acidosis less clear More hyperglylceamic and hyperosmolar?role of dialysis in correcting these abnormalities 1. Define the key abnormalities 2. How does this situation differ from standard DKA? 3. What are your management priorities? ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Glucose 73 <11 K Urea Creatinine 958 Osmolality
33 Case 2a: Presentation 1. Address hyperkalemia 2. Correct acidosis 3. Do no harm with treatment 1. Fluid overload 2. Overly rapid osmotic correction 4. Treat the underlying cause ph HCO CO Anion Gap > Β-OH Butyrate 9 <0.4 Lactate 11 <2 Na Define the key abnormalities 2. How does this situation differ from standard DKA? 3. What are your management priorities? Glucose 73 <11 K Urea Creatinine 958 Osmolality
34 Case 2a: Resolution Hour ph HCO CO BOHB Lactate PD exchange x mL Insulin 10 units stat then 5 units / hour 3 units / hour K hour totals Na Corr Na Gluc >38 >38 >38 > IVF L IV K + Nil 20mmol 20mmol 40mmol U/O IDC L
35 Case 2a: Resolution Hour ph HCO CO BOHB Lactate PD exchange x mL Insulin 10 units stat then 5 units / hour 3 units / hour K hour totals Na Corr Na Gluc >38 >38 >38 > IVF L IV K + Nil 20mmol 20mmol 40mmol U/O IDC L
36 Case 2a: Resolution Hour ph HCO CO BOHB Lactate PD exchange x mL Insulin 10 units stat then 5 units / hour 3 units / hour K hour totals Na Corr Na Gluc >38 >38 >38 > IVF L IV K + Nil 20mmol 20mmol 40mmol U/O IDC L
37 Case 2a: Resolution Hour ph HCO CO BOHB Lactate PD exchange x mL Insulin 10 units stat then 5 units / hour 3 units / hour K hour totals Na Corr Na Gluc >38 >38 >38 > IVF L IV K + Nil 20mmol 20mmol 40mmol U/O IDC L
38 Case 2a: Resolution Hour ph HCO CO BOHB Lactate PD exchange x mL Insulin 10 units stat then 5 units / hour 3 units / hour K hour totals Na Corr Na Gluc >38 >38 >38 > IVF L IV K + Nil 20mmol 20mmol 40mmol U/O IDC L
39 Estimate Case 1 IVF 1-2L K: 20mmol IVF 1-2L K: 20-40mmol IVF 1.5L K: 10-40mmol First 12 hours: 5L IVF and mmol K IVF 2.25L K: 10mmol IVF 2.85L K: 50mmol Resolution First 12 hours: 5.1L IVF and 60mmol K Case 2a IVF 2L K: Nil IVF 1L K: Nil IVF 1L K: 30mmol First 12 hours: 4L IVF and 30mmol K
40 Case 2a: Summary Severe DKA in a PD patient with lactic acidosis (hypoperfusion) With hyperkalemia Trigger: missed insulin and missed dialysis Resolution: Less IVF and K required than for standard severe DKA PD may have assisted with rapid resolution of acidosis Insulin infusion rate reduced to slow rate of correction of glucose once acidosis resolved
41 Case 2b: Ms B 49 year old Indigenous female. Type 2 diabetes mellitus Anti-GAD antibodies >2000iu/L (<10) Autoimmune hypothyroidism Sister has Type 1 Diabetes Microvascular complications End stage renal disease (diabetic nephropathy) Recently commenced on HD via permacath (previous PD peritonitis) Still passes urine Medications Lantus 90 units Novorapid 15 units TDS Metoprolol 12.5mg bd Aspirin 100mg Atorvastatin 40mg Clopidogrel 75mg Frusemide 80mg BD Calcitriol 0.25mcg Caltrate 2 tabs TDS Amlodipine 5mg Ezetimibe 10mg Macro-vascular complications IHD with 2x prior AMI
42 Case 2b: Presentation Epigastric pain and vomiting for 2 days Missed Lantus last night 2 episodes of diarrhoea Attended for HD at peripheral site Hyperglycaemic, unwell sent to JHH ED BP 160/64. P100. Afebrile Does not appear clinically overloaded Dry weight 88kg, Wt today 90.3kg ph HCO CO Anion Gap Β-OH Butyrate 4.6 <0.4 Lactate 2.7 <2 Na Glucose 50 <11 K Urea Creatinine 602
43 Case 2b: Presentation Epigastric pain and vomiting for 2 days Missed Lantus last night 2 episodes of diarrhoea Attended for HD at peripheral site Hyperglycaemic, unwell sent to JHH ED BP 160/64. Afebrile Does not appear clinically overloaded Dry weight 88kg, Wt today 90.3kg 1. Define the key abnormalities 2. What is your management priority 3. How does this situation differ from standard DKA? ph HCO CO Anion Gap Β-OH Butyrate 4.6 <0.4 Lactate 2.7 <2 Na Glucose 50 <11 K Urea Creatinine 602
44 Case 2b: Presentation Epigastric pain and vomiting for 2 days Missed Lantus last night 2 episodes of diarrhoea Attended for HD at peripheral site Hyperglycaemic, unwell sent to JHH ED BP 160/64. Afebrile Does not appear clinically overloaded Dry weight 88kg, Wt today 90.3kg 1. Define the key abnormalities 2. What is your management priority 3. How does this situation differ from standard DKA? ph HCO CO Anion Gap Β-OH Butyrate 4.6 <0.4 Lactate 2.7 <2 Na Glucose 50 <11 K Urea Creatinine 602
45 Case 2b: Presentation Mild high anion gap metabolic acidosis - Explained by ketones Hyperglyceamia with secondary hyponatremia ph HCO CO Anion Gap Β-OH Butyrate 4.6 <0.4 Lactate 2.7 <2 Na Define the key abnormalities 2. What is your management priority 3. How does this situation differ from standard DKA? Glucose 50 <11 K Urea Creatinine 602
46 Case 2b: Presentation Mild high anion gap metabolic acidosis - Explained by ketones Hyperglyceamia with secondary hyponatremia ph HCO CO Anion Gap Β-OH Butyrate 4.6 <0.4 Lactate 2.7 <2 Na Define the key abnormalities 2. What is your management priority 3. How does this situation differ from standard DKA? Glucose 50 <11 K Urea Creatinine 602
47 Case 2b: Presentation ph HCO CO Anion Gap Β-OH Butyrate 4.6 <0.4 Lactate 2.7 <2 Na Define the key abnormalities 2. What is your management priority 3. How does this situation differ from standard DKA? Glucose 50 <11 K Urea Creatinine 602
48 Case 2b: Presentation Priorities: 1. Correct acidosis by addressing ketosis 2. Correct hyperglycaemia 3. Manage volume status/hyperosmolality ph HCO CO Anion Gap Β-OH Butyrate 4.6 <0.4 Lactate 2.7 <2 Na Define the key abnormalities 2. What is your management priority 3. How does this situation differ from standard DKA? Glucose 50 <11 K Urea Creatinine 602
49 Case 2b: Presentation ph HCO CO Anion Gap Β-OH Butyrate 4.6 <0.4 Lactate 2.7 <2 Na Define the key abnormalities 2. What is your management priority 3. How does this situation differ from standard DKA? Glucose 50 <11 K Urea Creatinine 602
50 Case 2b: Presentation Differences: - Lower likelihood of potassium and water deficit due to lack of osmotic diuresis - Greater hyperosmolality / hyperglyceamia ph HCO CO Anion Gap Β-OH Butyrate 4.6 <0.4 Lactate 2.7 <2 Na Define the key abnormalities 2. What is your management priority 3. How does this situation differ from standard DKA? Glucose 50 <11 K Urea Creatinine 602
51 Case 2b: Resolution Hour Total ph HCO CO B-OH-B Lactate Dialysis withheld Dialysis given Insulin 5 units/hr 2 units/hr 1.5u/hr Stop K Na Corr Na Glucose 50 > IVF IV K + U/O Nil Not recorded 1000mL
52 Case 2b: Resolution Hour Total ph HCO CO B-OH-B Lactate Dialysis withheld Dialysis given Insulin 5 units/hr 2 units/hr 1.5u/hr Stop K Na Corr Na Glucose 50 > IVF IV K + U/O Nil Not recorded 1000mL
53 Case 2b: Resolution Hour Total ph HCO CO B-OH-B Lactate Dialysis withheld Dialysis given Insulin 5 units/hr 2 units/hr 1.5u/hr Stop K Na Corr Na Glucose 50 > IVF IV K + U/O Nil Not recorded 1000mL
54 Case 2b: Resolution Hour Total ph HCO CO B-OH-B Lactate Dialysis withheld Dialysis given Insulin 5 units/hr 2 units/hr 1.5u/hr Stop K Na Corr Na Glucose 50 > IVF IV K + U/O Nil Not recorded 1000mL
55 Estimate Case 1 IVF 1-2L K: 20mmol IVF 1-2L K: 20-40mmol IVF 1.5L K: 10-40mmol First 12 hours: 5L IVF and mmol K IVF 2.25L K: 10mmol IVF 2.85L K: 50mmol Resolution First 12 hours: 5L IVF and 60mmol K Case 2a IVF 2L K: Nil IVF 1L K: Nil IVF 1L K: 30mmol First 12 hours: 4L IVF and 30mmol K Case 2b IVF: Nil K: Nil IVF: Nil K: Nil IVF 1L K: Nil First 12 hours: 1L IVF and Nil K
56 Case 2b: Summary Mild metabolic acidosis due to DKA Resolved with IV insulin alone (no IVF or K) Trigger: Viral illness + inadequate Sick Day Education Not appropriate for DKA protocol Excess IVF + K + replacement? Too rapid correction of glucose Withholding dialysis to minimize osmotic shifts may have been beneficial
57 DKA in Dialysis patients Uncommon Altered physiology
58 How uncommon? ICD10 Audit : DKA codes (T1/T2DM) ESRD codes (dialysis, CKD) Manual review 10 patients, 11 episodes Approximately 1 case per year in HNE DKA Dialysis DKA Non-Dialysis p Presentations, n 11 (1%) 619 (99%) Patients, n Presentations, n per patient Age (mean, SD) 44 (10.2) 32.2 (14.3) p=0.01 Gender ratio (M:F, n, %) 6 : 5 (54 : 46) 256 : 363 (41 : 59) ns Mortality (n, %) 1/11 (9%) 12/619 (0.02%) p=0.09 LOS (median, IQR) 5 (3-9) 2 (1-4) p=0.01 Transferred from other facility 2 / 11 (18%) 85 / 619 (14%) ns
59 DKA in Dialysis patients Uncommon Longer insulin half-life Survivor bias Routine service contact Altered physiology Main difference is or lack of osmotic diuresis Minimal fluid loss Minimal potassium loss Insulin infusion is often the only treatment required.
60 DKA in Dialysis patients Uncommon Longer insulin half-life Survivor bias Routine service contact Altered physiology Main difference is or lack of osmotic diuresis Minimal fluid loss Minimal potassium loss Insulin infusion is often the only treatment required.
61 Tonicity = without urea Osmolality = with urea Rohrscheib, Adv Perit Dialy 2005
62 Serum Potassium mmol/l Serum K + at presentation DKA Non-DKA DKA Non-DKA Dialysis Non-Dialysis Tzamaloukas, Int Urol Neph 2011
63 Treatment with insulin alone Pooled analysis of observational studies of 130 patients with dialysis associated hyperglyceamia, treated with insulin alone (no fluids, no potassium). Study 18 includes 22 patients with DKA. Remainder have non-ketotic hyperglyceamia Strong correlation between magnitude of fall in potassium level and starting level of potassium in all studies. Tzamaloukas, Int Urol Neph 2011
64 Comments: DKA in Dialysis DKA in dialysis patients is uncommon About 1 per year in our area. First principles management is probably right DKA protocol not appropriate gives more fluid and K + than required Many patients may not require supplemental K + or fluids Insulin is the main treatment required. Unclear if a slower rate of infusion is optimum given tendency to significant hyperglycaemia Recommended rate of fall of glucose: 3-5mmol/hour
65 Case 3: Ms B 35. Female T1DM, diagnosed age 28 Levemir 13 units BD Novorapid 2-3 units / 15g CHO TDS HbA1c 8.5% Autoimmune hypothyroidism Social Lives alone. Independent Works in Pharmaceutical Industry Non smoker. Minimal alcohol.
66 Case 3: Presentation Self-presented to ED day history of nausea, abdominal pain Now developed thirst and polyuria Looks unwell Dry mucous membranes. T36. HR 100. BP 120/70. BGL 8.9mmol/L No septic focus. Taking canagliflozen (bought on internet) 1. Explain the biochemical abnormalities 2. What treatment does this patient need? ph HCO CO Anion Gap Β-OH Butyrate 6.1 <0.4 Lactate 0.9 <2 Na Glucose 9.6 <11 K Urea Creatinine 71
67 Case 3: Presentation Euglycaemic diabetic ketoacidosis - Moderate severity - Clear ketosis Due to inadequate exogenous insulin - Pharmacological renal glucose wasting Insulin and glucose (and K + ) 1. Explain the biochemical abnormalities 2. What treatment does this patient need? ph HCO CO Anion Gap Β-OH Butyrate 6.1 <0.4 Lactate 0.9 <2 Na Glucose 9.6 <11 K Urea Creatinine 71
68 Case 3: Presentation Euglycaemic diabetic ketoacidosis - Moderate severity - Clear ketosis Due to inadequate exogenous insulin - Pharmacological renal glucose wasting Insulin and glucose (and K + ) 1. Explain the biochemical abnormalities 2. What treatment does this patient need? ph HCO CO Anion Gap Β-OH Butyrate 6.1 <0.4 Lactate 0.9 <2 Na Glucose 9.6 <11 K Urea Creatinine 71
69 Case 3: Resolution Time Ref ph HCO CO Anion Gap Β-OH Butyrate <0.4 Glucose <11 K IV insulin 2 units / hr IV Saline IV Dextrose 125ml/hr IV K
70 Case 3: Further history Current Pharmacotherapy Canagliflozen 100mg BD (internet pharmacy) Phentaramine 30mg daily Metformin 2000mg daily Self prescribed VLCD (<45g/day) No ketone monitoring at home Unwell for 2 days prior to presentation Vomiting, dehydration Treated with water as BGLs 9-10mmol/L, but no extra insulin Urinary ketones strongly positive!
71 Comments: SGLT2 associated DKA Euglycaemic DKA secondary to SGLT-2 inhibitors Many case reports in the literature Often a second hit required (SGLT2 probably reduces threshold for ketosis) - Low calorie diet further reduction of insulin requirements In T1DM Renal glucose wasting artificially lowers insulin requirements lipolysis and ketogenesis Early evidence emerging that SGLT2 may have a role in management of T1DM Patient education, safety monitoring are essential.
72 Early evidence for SGLT2 in T1DM HbA1c Weight Trials limited to ~100 pts and < 12 weeks Not TGA approved. Significant safety caveats not addressed Chen, Scientific Reports, 2017
73 SGLT2 in T2DM Empagliflozen (Jardiance) Dapagliflozen (Forxiga) Canagliflozen (Invokana) Independent of insulin action Dependent on GFR + glucose % reduction in HbA1c 2-3kg wt loss Modest antihypertensive effect 1 in 20 excess thrush / yr Osmotic diuresis (1 void/24 hrs) Second or third line agent as add on to metformin
74 What s all the fuss with Empa- Zinman, N Eng J Med 2015
75 Don t believe everything you re told The findings from this study need to be kept in perspective. The large benefit of empagliflozin, while impressive, was in a very high-risk population with established CVD at baseline. Moreover, the difference in glycemia between the treatment groups was minimal, suggesting that extra-glycemic effects of the drug were responsible for the CVD outcome. Whether the salutary cardiovascular effects in those with overt CVD are specific to empagliflozin, or represent a class effect of the SGLT2 inhibitors, will await publication of the canagliflozin and dapagliflozin cardiovascular trials in progress. In addition, it is unknown whether empagliflozin, or other SGLT2 inhibitors, will have similar CVD effects in the majority of persons with type 2 diabetes who do not have overt CVD. Anthony DeSantis, MD, Uptodate
76 In summary HNE DKA Protocol has been in use for 6 years Safe, effective protocol based care Appropriate for use in most circumstances Protocols do not replace need for thoughtful, individualised patient care Highlighted by cases of abnormal physiology (dialysis, pregnancy, pharmacotherapy)
77 Comments Protocols are part of 21 st Century medical care Senior clinical leadership in teams to model patient centered care through: Thoughtful adherence to protocols in most circumstances Cautious, considered and occasional protocol deviation Consult before you depart from standard of care. The DKA protocol has stood the test of time. Use it!
Inpatient Diabetes 20/01/2015. What should I do? Hyperglycaemia why does it matter? Why are the BSLs unstable? BSL parameters
Hyperglycaemia why does it matter? Inpatient Diabetes Angela Sheu Endocrine Registrar St George Hospital Hyperglycaemia at admission is a predictor of mortality May be part of stress response (eg post
More informationCOMPLIANCE WITH THIS DOCUMENT IS MANDATORY
COVER SHEET `NAME OF DOCUMENT TYPE OF DOCUMENT at Shoalhaven Hospital Group Critical Care Procedure DOCUMENT NUMBER DATE OF PUBLICATION February 2018 RISK RATING Medium REVIEW DATE February 2021 FORMER
More informationHyperglycaemic Emergencies GRI EDUCATION
Hyperglycaemic Emergencies GRI EDUCATION LEARNING OUTCOMES Develop and describe your system of blood gas interpretation and recognise common patterns of acid-base abnormality. Describe the pathophysiology
More informationManagement of Adult patients with Diabetic Ketoacidosis (DKA) & Hyperosmolar Non-ketotic Coma (HONK) Most current literature relevant to critical care
NAME OF DOCUMENT TYPE OF DOCUMENT Management of Adult patients with Diabetic Ketoacidosis (DKA) & Hyperosmolar Non-ketotic Coma (HONK) GUIDELINE DOCUMENT NUMBER ED CLIN GL 04 DATE OF PUBLICATION May 2013
More informationSCENARIO. Maternal Medicine -DKA LEARNING OBJECTIVES
SCENARIO Maternal Medicine -DKA LEARNING OBJECTIVES Recognition of the of the seriously ill patient Diagnosis of DKA in pregnancy Recognition of precipitating factors for DKA Initiate emergency management
More informationVinaya Simha, M.D. Assistant Professor, Division of Endocrinology
Vinaya Simha, M.D. Assistant Professor, Division of Endocrinology Faculty photo will be placed here Simha.aj@mayo.edu 2015 MFMER 3543652-1 Diabetic Ketoacidosis a few pearls Mayo School of Continuous Professional
More informationAACN PCCN Review. Endocrine
AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders
More informationDiabetic Ketoacidosis
October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent
More informationPlease inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.
Adult Diabetic Ketoacidosis Care Bundle (V1. Issued October 2014 Review October 2015) Improving patient care This pack includes: DKA Management Guideline Name: (Patient Addressograph) DOB: Hospital No:
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationPERIOPERATIVE DIABETES GUIDELINE
PERIOPERATIVE DIABETES GUIDELINE This Guideline does not replace the need for the application of clinical judgment in respect to each individual patient. Background Diabetes mellitus is estimated to affect
More informationCountry Health SA Local Health Network
Country Health SA Local Health Network Protocol (Clinical) Title: Hyperglycaemic Hyperosmolar State Management in Adults with Type 2 Diabetes Protocol developed by: CHSALHN Diabetes Service Protocol Sponsor:
More informationCountry Health SA Local Health Network. Version control and change history
Country Health SA Local Health Network Protocol (Clinical) Title: Diabetic Ketoacidosis Management in Adults with Type 1 Diabetes Protocol developed by: CHSALHN Diabetes Service Protocol Sponsor: CHSALHN,
More informationDiabetic Ketoacidosis
Diabetic Ketoacidosis Definition: Diabetic Ketoacidosis is one of the most serious acute complications of diabetes. It s more common in young patients with type 1 diabetes mellitus. It s usually characterized
More informationWith Dr. Sarah Reid and Dr. Sarah Curtis
5. Headaches 6. Known diabetes 7. Specific high risk groups (ie. Teenagers, children on insulin pumps and those from lower socio-economic status). Episode 63 Pediatric Diabetic Ketoacidosis With Dr. Sarah
More informationDiabetic Keto Acidosis
Diabetic Keto Acidosis Dr Jeremy Turner MRCP D.Phil Consultant Physician, Elsie Bertram Diabetes Centre Norfolk and Norwich University Hospital What is the definition of DKA? Diabetic ketoacidosis is defined
More informationADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center
- Phase: Begin Immediately/Emergency Center Weight PHYSICIAN S Allergies Admit/Discharge/Transfer Patient Status Requested Location: MICU, Pt Status: Inpatient (LOS > 2 midnights) Requested Location: 5E
More informationLynda Astbury Lead Diabetes Specialist Nurse
Lynda Astbury Lead Diabetes Specialist Nurse WARNING SIGNS AND SYMPTOMS Is patient Feeling unwell? Blood glucose level above 13mmol/L Or higher than the patients day to day readings (even if not eating)
More informationObjectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)
Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow June 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood Glucose
More informationDIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1
DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1 QUESTION # 1 7 year old boy comes to the ER with a 2 week history of abdominal pain and weight loss. Further history reveals polyuria and polydipsia,
More informationInpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham
Inpatient Diabetes and Hyperglycaemia Philip Dyer Heart of England NHS Foundation Trust Birmingham A Case of Inpatient Diabetes 22.09.15 Mrs DE Ketosis-prone T2DM on bd Humulin-I, Metformin and Linagliptin
More informationErtugliflozin (Steglatro ) 5 mg daily. May increase to 15 mg daily. Take in the morning +/- food. < 60: Do not initiate; discontinue therapy
Sodium-glucose Cotransporter-2 (SGLT2) s Inhibit SGLT in proximal renal tubules, reducing reabsorption of filtered glucose from tubular lumen Lowers renal threshold for glucose à increase urinary excretion
More informationObjectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)
Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow September 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood
More informationADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES
ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES DEFINITION -Glucose >250 mg/dl*, anion gap > 16, + ketones * Glucose < 250 does not exclude DKA especially if anion gap >
More informationDiabetes, Ketone testing in Type 1 Diabetes
CLINICAL GUIDELINE Diabetes, Ketone testing in Type 1 Diabetes A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised
More informationCDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017
CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017 DKA at organ level 3 Diabetic Ketoacidosis Characteristics Ketones positive Anion Gap > 12 (High) Blood Sugar > 14 (High) Bicarbonate
More informationRenal and Urology Fellowship Questions
Renal and Urology Fellowship Questions HOT TOPICS UTI/Pyelonephritis - paed Acute Renal Failure Rhabdomyolysis Hyperkaleamia dialysis patient Subacute Bacterial Peritonitis in PD Patient Renal Transplant
More informationDiabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy
Diabetes in Renal Patients Contents Understanding Diabetic Nephropathy What effect does CKD have on a patient s diabetic control? Diabetic Drugs in CKD and Dialysis Patients Hyper and Hypoglycaemia in
More informationFor The Management Of. Diabetic Ketoacidosis
Guidelines For The Management Of Diabetic Ketoacidosis By Dr. Sinan Butrus F.I.C.M.S Clinical Standards & Guidelines Dr.Layla Al-Shahrabani F.R.C.P (UK) Director of Clinical Affairs Kurdistan Higher Council
More informationDept of Diabetes Main Desk
Dept of Diabetes Main Desk 01202 448060 Glucose management in Type 2 Diabetes in Adults The natural history of type 2 diabetes is for HbA1c to deteriorate with time. A stepwise approach to treatment is
More informationCase TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air
Mr N is a 64year old Chinese gentleman who is a heavy drinker, still actively drinking, and chronic smoker of >40pack year history. He has a past medical history significant for Hypertension, Hyperlipidemia,
More informationDrug Class Monograph
Drug Class Monograph Class: Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors Drugs: Farxiga (dapagliflozin), Invokamet (canagliflozin/metformin), Invokana (canagliflozin), Jardiance (empagliflozin),
More informationUse this version only
Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS (DKA) Use this version only Patient Label Details Ward: Consultant: Named Nurse: Date of Admission: Date of Discharge/Transfer: ALL STAFF TO WRITE
More informationdiabetes in adults Metabolic complications of
Metabolic complications of diabetes in adults Dimitri MARGETIS MD ICU St ANTOINE PARIS Definition Diabetic acidoketosis Serious complication in type I diabetes : Hyperglycemia Metabolic acidosis Acidic
More informationTOO SWEET TOO STORMY. CONSULTANTS: Dr. Saji James Dr. J. Dhivyalakshmi Dr. P. N. Vinoth. PRESENTOR: Dr. Abhinaya PG I (M.D Paeds)
TOO SWEET TOO STORMY PRESENTOR: Dr. Abhinaya PG I (M.D Paeds) CONSULTANTS: Dr. Saji James Dr. J. Dhivyalakshmi Dr. P. N. Vinoth Unit IV, Dept. Of Paediatrics, SRMC & RI 14year old female complaints of
More informationSARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE
SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: DKA / HHNS PATIENTS REQUIRING INTRAVENOUS INSULIN DRIPS -ADULTS Nursing DATE: REVIEWED: PAGES: 12/14 5/18 1 of 8 RESPONSIBILITY: *RN (Renal/Diabetes/Wound
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE TREATMENT OF HYPERGLYCEMIA - ADULT SCOPE Provincial: Acute Care APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Diabetes, Obesity & Nutrition Strategic Clinical Network PARENT
More informationHyperglycemia Procedure: Management and Treatment Adult Patients
Approved by: Chief Operating Officer; and Chief Medical Officer Hyperglycemia Procedure: Management and Treatment Corporate Policy & Procedures Manual Number: VII-B-465 Date Approved January 23, 2018 Date
More informationHHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION!
Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours Page 1 of 2 Time of Arrival Loca8on Date / / Diagnosis the characteris8c features of a person with HHS are a) Hypovolaemia b) Marked
More informationArterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)
Page 1 of 6 Hyperglycemic Emergency Management (DKA/HHS 1 ) - Adult PATIENT PRESENTATION Patient with history of Type 1 or 2 Diabetes Mellitus or presenting with polyuria, polydipsia, nausea/ vomiting,
More informationDiabetic Ketoacidosis (DKA)
Diabetic Ketoacidosis (DKA) Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Date of submission February
More informationMore Than Just the Numbers:
More Than Just the Numbers: Individualising Patient Care ADEA-QLD Branch Conference 20 April 2018 Case Study 1 Child with Type 1 Diabetes 2 Background and Social History 10 year old female with T1DM since
More informationArterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)
Page 1 of 6 Hyperglycemic Emergency Management (DKA/HHS 1 ) - Adult PATIENT PRESENTATION Patient with history of Type 1 or 2 Diabetes Mellitus or presenting with polyuria, polydipsia, nausea/ vomiting,
More informationPediatric Diabetic Ketoacidosis (DKA) General Pediatrics Admission Order Set
Admitting MRP: Pediatrics: Dr. / Dr. on call to cover until 08:00 am Service: Medicine Team 1 Medicine Team 2 Medical subspecialty Diagnosis: Diabetic Ketoacidosis (DKA) Estimated length of stay Less than
More informationGuidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group
Guidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group 1. Introduction 1.1 This document sets out the University Hospitals of Leicester (UHL) guidelines
More informationPre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013
Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 www.diabetesvic.org.au Plan/ overview Issue/ presenting problems
More informationELECTROLYTES RENAL SHO TEACHING
ELECTROLYTES RENAL SHO TEACHING Metabolic Alkalosis 2 factors are responsible for generation and maintenance of metabolic alkalosis this includes a process that raises serum bicarbonate and a process that
More informationAcute Kidney Injury (AKI) Undergraduate nurse education
Acute Kidney Injury (AKI) Undergraduate nurse education Year Three Developed Summer 2017 Objectives Understand Acute Kidney Injury and its relevance to patient care. Brief revision of the Anatomy and physiology
More informationTable 1. Common precipitating events of DKA.
Update in Anaesthesia Diabetic ketoacidosis Claire Preedy and William English Correspondence Email: englishwilliam@hotmail.com DEFINITION Diabetes ketoacidosis (DKA) is a medical emergency. It is classified
More information10. ACUTE COMPLICATIONS OF DIABETES MELLITUS
10. ACUTE COMPLICATIONS OF DIABETES MELLITUS Prof. Oren Zinder, Ph.D. Rambam Medical Center, and the Technion Faculty of Medicine, Haifa, Israel 1.1. Hypoglycaemia Hypoglycaemia is a lowered blood glucose
More informationSGLT2 Inhibitors
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.19 Subject: SGLT2 Inhibitors Page: 1 of 6 Last Review Date: September 15, 2016 SGLT2 Inhibitors Description
More informationPHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG
DRUG AND TREATMENT *****ALSO ORDER SUB ACUTE DKA IV FLUIDS REGIMEN & SUB ACUTE ELECTROLYTE REPLACEMENT on separate forms ***** Condition/Status For purpose of this DKA Regimen, DKA is considered clear
More informationINTRAVENOUS FLUID THERAPY
INTRAVENOUS FLUID THERAPY PRINCIPLES Postnatal physiological weight loss is approximately 5 10% in first week of life Preterm neonates have more total body water and may lose 10 15% of their weight in
More informationDiabetic ketoacidosis Expiry date 2005
Diabetic ketoacidosis Expiry date 2005 PREVALENCE Diabetic ketoacidosis is defined as [D] 1 : hyperglycaemia (> 14 mmol/l) metabolic acidosis (ph < 7.35 or bicarbonate < 15 mmol/l) high anion gap (anion
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Diabetic Ketoacidosis. These podcasts are designed to give medical students an overview of key topics in pediatrics.
More informationINTRAVENOUS FLUIDS PRINCIPLES
INTRAVENOUS FLUIDS PRINCIPLES Postnatal physiological weight loss is approximately 5-10% Postnatal diuresis is delayed in Respiratory Distress Syndrome (RDS) Preterm babies have limited capacity to excrete
More informationHYPONATRAEMIA: NUH GUIDELINE FOR INITIAL ASSESSMENT AND MANAGEMENT.
HYPONATRAEMIA: NUH GUIDELINE FOR INITIAL ASSESSMENT AND MANAGEMENT. HYPONATRAEMIA: SODIUM < 130 MMOL/L SIGNIFICANT. Symptoms/signs usually only occur when sodium < 125 mmol/l. Acute hyponatraemia is less
More informationDIABETES MELLITUS. IAP UG Teaching slides
DIABETES MELLITUS 1 DIABETES MELLITUS IN CHILDREN Introduction, Definition Classification, pathogenesis Clinical features Investigations and diagnosis Therapy and follow up Complications Carry home message
More informationDIABETIC KETOACIDOSIS MANAGEMENT PLAN:
DIABETIC KETOACIDOSIS MANAGEMENT PLAN: 1. Assessment (weight, blood glucose level (BGL), blood pressure (BP), heart rate (HR), respiratory rate (RR), temperature, history & examination) 2. Resuscitation
More information01/09/2017. Outline. SGLT 2 inhibitor? Diabetes Patients: Complex and Heterogeneous. Association between diabetes and cardiovascular events
MICROVASCULAR COMPLICATIONS Incidence of outcome g 1 Cardioprotective Effects of SGLT2s Relevant for Which T2 Diabetes Patient? SGLT 2 inhibitor? 58 year old, waist circumference 5 cm, PMH: IHD On statin,
More informationISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)
Contact Details Name: Hospital Telephone: This protocol has 5 pages ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version) Please read carefully. Meticulous treatment is very important as there
More information28-Aug-15. RACGP guidelines 2014/15. ADS guidelines Part 1 T2D Guidelines. Part 2 What comes after metformin?
Part 1 T2D Guidelines Oral therapies in T2 diabetes Dr Gary Kilov T2D Guidelines - What s New? What comes after metformin? 1 RACGP guidelines 2014/15 ADA-EASD: Anti-Hyperglycaemic therapy 2015 3 4 Inzucchi
More informationExecutive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)
Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young
More informationNothing to disclose. Disclosure
Nothing to disclose. Disclosure Inpatient Management of Diabetes Mellitus Cindy Chin, MD Pediatrics in the Red Rocks 2015 Objectives Name 3 diagnostic criteria for diabetes mellitus. Understand and apply
More informationDIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address:
1 DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address: 2 Learning Outcomes All nurses, regardless of practice setting, are required to work collaboratively with the person
More informationDiabetes mellitus - diagnosis, classification and acute complications. David Karásek 3rd Department of Internal Medicine University Hospital Olomouc
Diabetes mellitus - diagnosis, classification and acute complications David Karásek 3rd Department of Internal Medicine University Hospital Olomouc Diabetes mellitus is a group of metabolic diseases, characterized
More informationI have no financial disclosures
Athina Sikavitsas DO Children's Emergency Services University of Michigan Discuss DKA Presentation Assessment Treatment I have no financial disclosures 1 6 Y/O male presents with vomiting and abdominal
More informationSGLT2 Inhibitors
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: SGLT2 Inhibitors Page: 1 of 7 Last Review Date: June 22, 2018 SGLT2 Inhibitors Description Invokana
More informationDKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014
DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol Glycemic Task Force September 2014 Hyperglycemic Crises: Pathophysiology DKA HHS Hyperglycemia DKA HHS Umpierrez, In Shoemaker,
More informationGuideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation
CHILDREN S SERVICES Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation Background Surgery places stress on the body and will alter glucose control and insulin
More informationTREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse
TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationDIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor
DIABETES AND PREGNANCY CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor OBJECTIVES Describe targets for blood glucose in pregnancy Discuss the risks to baby if blood glucose
More informationDrug Therapy for Diabetes Mellitus. Adj A/Prof Daniel Chew Dept of Endocrinology 8 th July 2017
Drug Therapy for Diabetes Mellitus Adj A/Prof Daniel Chew Dept of Endocrinology 8 th July 2017 Diabetes Subtypes Optimal Treatment Ominous Octet DeFronzo. DIABETES, VOL. 58, APRIL 2009 Schematic Overview
More informationDiabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System
Critical Care Guideline Two Bag System Inclusion Criteria (Definition of DKA): Blood glucose (BG) > 200 mg/dl Acidosis (bicarbonate < 15 or blood gas ph < 7.3) Associated glycosuria, ketonuria &/or ketonemia
More informationA case of DYSELECTROLYTEMIA. Dr. Prathyusha Dr. Lalitha janakiraman s unit
A case of DYSELECTROLYTEMIA Dr. Prathyusha Dr. Lalitha janakiraman s unit CASE SUMMARY 4 month old, female infant 1 st born to NC parents, term, b.wt: 3.25kg No neonatal hospitalization Attained head control
More informationGuidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010
Guidelines to assist General Practitioners in the Management of Type 2 Diabetes April 2010 Foreword The guidelines were devised by the Diabetes Day Centre in Beaumont Hospital in consultation with a number
More informationManaging Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines
Document Control Title Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Author Author s job title Specialist Nurse Consultant Physician Department Directorate Unscheduled Care Version Date
More informationSGLT2 Inhibitors
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: SGLT2 Inhibitors Page: 1 of 7 Last Review Date: November 30, 2018 SGLT2 Inhibitors Description
More informationSGLT2 Inhibitors
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.07.19 Subject: SGLT2 Inhibitors Page: 1 of 5 Last Review Date: December 3, 2015 SGLT2 Inhibitors Description
More informationStaff at the Nottingham Children s Hospital. Guidelines process.
Diabetes and Surgery Title of Guideline Contact Name and Job Title (author) Guideline for the management of children and young people with diabetes aged 18 or under requiring surgery Dr Priyha Santhanam,
More informationDiabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State. Adam Bursua, Pharm.D., BCPS
Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State Adam Bursua, Pharm.D., BCPS Objectives Describe the epidemiology of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar
More informationSodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors Drug Class Prior Authorization Protocol
Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has
More informationDKA Adult ICU Powerplan
DKA Adult ICU Powerplan Key Points for ED to ICU DKA power plan In addition to NS fluids and maintenance the regular insulin drip will either already be infusing from ED or needs to be initiated. Regular
More informationDRUG ALLERGIES WT: KG
DRUG AND TREATMENT Acute Diabetic Ketoacidosis Condition/Status ***(NOTE)*** For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS
More informationDiabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
More informationImproved IPGM: Demonstrating the Value to both Patients and Hospitals
Improved IPGM: Demonstrating the Value to both Patients and Hospitals Osama Hamdy, MD, PhD, FACE Medical Director, Inpatient Diabetes Program Joslin Diabetes Center Harvard Medical School, Boston, MA Cost
More informationBasic Fluid and Electrolytes
Basic Fluid and Electrolytes Chapter 22 Basic Fluid and Electrolytes Introduction Infants and young children have a greater need for water and are more vulnerable to alterations in fluid and electrolyte
More informationDiabetes in the Elderly 1, 2, 3
Diabetes in the Elderly 1, 2, 3 WF Mollentze Feb 2010 Diabetes in the elderly differs from diabetes in younger people Prevalence: o Diabetes increases with age affecting approximately 10% of people over
More informationMANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY
MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY Background Management is different in different groups of women with diabetes. Women with Type 1 Diabetes (previously
More informationDiabetes Related Emergencies
Diabetes Related Emergencies Dr Ketan Dhatariya MBBS MSc MD MS FRCP PhD Consultant in Diabetes and Endocrinology Norfolk and Norwich University Hospitals Disclosures I am the lead author of the updated
More informationDr A Pokrajac MD MSc MRCP Consultant
Dr A Pokrajac MD MSc MRCP Consultant Onset at 5-15 years of T1DM Can be present at diagnosis of T2DM Detect in regular MA/Cr screening (2X first urine sample, no UTI, no other causes) Contributing Factors
More informationPeri-operative management of the surgical patient with diabetes GL059
DT Peri-operative management of the surgical patient with diabetes GL059 Approval Approval Group Job Title, Chair of Committee Date Anaesthetics Clinical Governance Chair Anaesthetic governance Nov 2016
More informationElectrolyte and Acid-Base Disturbances
Electrolyte and Acid-Base Disturbances Dr Martin Gallagher Head of Department, Renal Medicine CRGH Rahul Sud Renal Advanced Trainee Case 1 ME, 56 yo F BIBA Found by neighbour- confused state at home Feeling
More informationDiabetes Mellitus: Overview and Guidelines
Diabetes Mellitus: Overview and Guidelines Rezvan Salehidoost, M.D., Endocrinologist Abidi Diabetes Master Class IMPORTANCE? Why is it interesting to do research in diabetes J. Olefsky, JAMA 2001:285:628-632
More informationFluid & Electrolyte Balances in Term & Preterm Infants. Carolyn Abitbol, M.D. University of Miami/ Holtz Children s Hospital
Fluid & Electrolyte Balances in Term & Preterm Infants Carolyn Abitbol, M.D. University of Miami/ Holtz Children s Hospital Objectives Review maintenance fluid & electrolyte requirements in neonates Discuss
More informationNHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes
Guidelines for the Diagnosis of Diabetes Mellitus NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes Lead Authors: Dr Brian Kennon, Dr David Carty June 2015 Review due: December 2016 Diagnosis
More informationSTEP 3: Add or Substitute with one of
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationDiabetic Ketoacidosis in a Hospital Based Population in Pakistan
Diabetic Ketoacidosis in a Hospital Based Population in Pakistan Abstract Pages with reference to book, From 139 To 140 J. Akhter, A. Jabbar, N. Islam, M.A. Khan ( Department of Medicine, Aga Khan University
More informationA Mnemonic for the Treatment of Hyperkalemia. Nick Wolters, PGY1 Resident Grandview Medical Center
A Mnemonic for the Treatment of Hyperkalemia Nick Wolters, PGY1 Resident Grandview Medical Center Hyperkalemia 30 YOF, ESRD, missed 2 dialysis sessions over the last week Potassium level came back at 7
More information